Literature DB >> 8700116

Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.

N Almaula1, B J Ebersole, J A Ballesteros, H Weinstein, S C Sealfon.   

Abstract

An important determinant of the neurobehavioral responses induced by a drug is its relative receptor selectivity. The molecular basis of ligand selectivity of hallucinogenic and nonhallucinogenic compounds of varying structural classes for the human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors was investigated with the use of reciprocal site-directed mutagenesis. Because these two closely related receptor subtypes differ in the amino acid present at position 5.46 (residues 242 and 222 in the sequences, respectively), the effects of corresponding substitutions in the 5-HT2A[S5.46(242)-->A] and 5-HT2C[A5.46(222)-->S] receptors were studied in tandem. By studying both receptors, the direct and indirect effects of mutations on affinity and selectivity can be distinguished. The ergolines studied, mesulergine (selective for the 5-HT2C receptor) and d-lysergic acid diethylamide (selective for the 5-HT2A receptor), reversed their relative affinity with mutations in each receptor, supporting a direct role of this locus in the selectivity of these ligands. However, interchange mutations in either receptor led to decreased or unchanged affinity for (+/-)-1-)(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and ketanserin, which have higher affinity for the 5-HT2A receptor, consistent with little contribution of this locus to the selectivity of these ligands. The indoleamines studied were affected differently by mutations in each receptor, suggesting that they bind differently to the two receptor subtypes. Mutation of this locus in the 5-HT2A receptor decreased the affinity of all indoleamines, whereas the interchange mutation of the 5-HT2C receptor did not affect indoleamine affinity. These results are consistent with a direct interaction between this side chain and indoleamines for the 5-HT2A receptor but not for the 5-HT2C receptor. Furthermore, this analysis shows that the higher affinity of 5-HT and tryptamine for the 5-HT2C receptor than for the 5-HT2A receptors is not due to the difference at this locus. The hallucinogens studied [d-lysergic acid diethylamide, psilocin, bufotenin, and (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane] fell into different classes in this analysis. For the classes of ligand studied, the side-chain difference at this position directly determines relative ligand selectivity only for ergolines and may contribute to the specific effects of hallucinogens in this class.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700116

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  22 in total

1.  Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.

Authors:  J Mialet; Y Dahmoune; F Lezoualc'h; I Berque-Bestel; P Eftekhari; J Hoebeke; S Sicsic; M Langlois; R Fischmeister
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 2.  Structure and function of serotonin G protein-coupled receptors.

Authors:  John D McCorvy; Bryan L Roth
Journal:  Pharmacol Ther       Date:  2015-01-17       Impact factor: 12.310

3.  Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Authors:  Landon M Klein; Nicholas V Cozzi; Paul F Daley; Simon D Brandt; Adam L Halberstadt
Journal:  Neuropharmacology       Date:  2018-02-27       Impact factor: 5.250

4.  Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors.

Authors:  Soo-Kyung Kim; Youyong Li; Ravinder Abrol; Jiyoung Heo; William A Goddard
Journal:  J Chem Inf Model       Date:  2011-02-07       Impact factor: 4.956

5.  Molecular interactions between general anesthetics and the 5HT2B receptor.

Authors:  Felipe Matsunaga; Lu Gao; Xi-Ping Huang; Jeffery G Saven; Bryan L Roth; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2013-12-23

6.  Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Authors:  Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

7.  A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor.

Authors:  James J Chambers; David E Nichols
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

8.  Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.

Authors:  Adam L Halberstadt; Ivan S Sindhunata; Kees Scheffers; Aaron D Flynn; Richard F Sharp; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-03-25       Impact factor: 5.250

9.  Importance of the second extracellular loop for melatonin MT1 receptor function and absence of melatonin binding in GPR50.

Authors:  Nathalie Clement; Nicolas Renault; Jean-Luc Guillaume; Erika Cecon; Anne-Sophie Journé; Xavier Laurent; Kenjiro Tadagaki; Francis Cogé; Arnaud Gohier; Philippe Delagrange; Philippe Chavatte; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-10-27       Impact factor: 8.739

10.  Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.

Authors:  Clinton E Canal; Tania Cordova-Sintjago; Yue Liu; Myong S Kim; Drake Morgan; Raymond G Booth
Journal:  J Pharmacol Exp Ther       Date:  2013-09-30       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.